Topic Hub
9 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 9 of 9 clinical reviews.
Metabolic syndrome and mental health disorders share biological pathways involving inflammation, cortisol dysregulation, and insulin resistance. Learn how depression, anxiety, schizophrenia, and bipolar disorder intersect with cardiometabolic risk.
Read clinical reviewA clinician-reviewed guide to exercise protocols for metabolic syndrome, including aerobic, resistance, and combined training prescriptions backed by AHA, ADA, and AACE guidelines.
Read clinical reviewHow genetics and family history shape metabolic syndrome risk, which gene variants matter most, and what clinicians recommend for people with inherited predisposition.
Read clinical reviewEvidence-based guide to diagnosing and treating metabolic syndrome in children, older adults, women with PCOS, transplant recipients, and other special populations. Includes criteria modifications, pharmacotherapy, and monitoring protocols.
Read clinical reviewA guideline-backed monitoring schedule for metabolic syndrome, including lab tests, visit intervals, and clinical targets from ADA, AACE, and the Endocrine Society.
Read clinical reviewEvidence-based nutrition and lifestyle protocols for metabolic syndrome, including dietary patterns, exercise prescriptions, and behavioral interventions backed by major clinical trials and society guidelines.
Read clinical reviewEvidence-based, stepwise treatment algorithm for metabolic syndrome organized by first-, second-, and third-line therapies. Covers lifestyle, pharmacotherapy, and surgical options per ADA, AACE, and Endocrine Society guidelines.
Read clinical reviewA clinical guide to the conditions that cluster with metabolic syndrome, including type 2 diabetes, cardiovascular disease, NAFLD, PCOS, and sleep apnea, with evidence-based management strategies.
Read clinical reviewA clinical review of the most promising metabolic syndrome research, from GLP-1 receptor agonists and dual-incretin therapies to SGLT2 inhibitors, PPAR agonists, and microbiome-targeted interventions.
Read clinical review